These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6602955)

  • 61. Zinc and cell-mediated immunity in chronic uremia.
    Bonomini M; Manfrini V; Cappelli P; Albertazzi A
    Nephron; 1993; 65(1):1-4. PubMed ID: 8413766
    [No Abstract]   [Full Text] [Related]  

  • 62. [In-vitro reactivity of lymphocyte function in chronic uremia].
    Fan CD; Liu JY; Shou L; Huang HW
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):668-74. PubMed ID: 6594428
    [No Abstract]   [Full Text] [Related]  

  • 63. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance.
    Krawczyk W; Marczewski K; Ledwozyw A
    Clin Nephrol; 1995 Nov; 44(5):340. PubMed ID: 8605718
    [No Abstract]   [Full Text] [Related]  

  • 65. [HDL-cholesterol in chronic uremia during hemodialytic treatment].
    Solinas A; Demelia L; Cogoni G; Porcu A; Civolani P; Usai E; Pitzus F
    Minerva Nefrol; 1981; 28(4):455-60. PubMed ID: 7339513
    [No Abstract]   [Full Text] [Related]  

  • 66. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.
    Brodersen HP; Holtkamp W; Larbig D; Beckers B; Thiery J; Lautenschläger J; Probst HJ; Ropertz S; Yavari A
    Nephrol Dial Transplant; 1995; 10(9):1780. PubMed ID: 8559509
    [No Abstract]   [Full Text] [Related]  

  • 67. Epidemiologic profile of anti-pig natural antibodies in the Taiwan population.
    Chao SH; Chu SH; Lin CY; Hsieh RP; Chen KM
    Transplant Proc; 1994 Jun; 26(3):1369-71. PubMed ID: 8029944
    [No Abstract]   [Full Text] [Related]  

  • 68. The immunologic capability of uremic patients.
    Merrill JP
    Cancer Res; 1968 Jul; 28(7):1449-51. PubMed ID: 4874991
    [No Abstract]   [Full Text] [Related]  

  • 69. [Pericarditis in patients with uremia].
    Krasojević-Kostić I; Asković D; Macura D; Stojković D; Velimirović D
    Srp Arh Celok Lek; 1982 Nov; 110(11):1311-24. PubMed ID: 7185184
    [No Abstract]   [Full Text] [Related]  

  • 70. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HLA associated cytotoxic antibody production in dialyzed chronic uraemic patients.
    Kovanecz I; Petri I; Kaiser G
    Acta Microbiol Immunol Hung; 1995; 42(1):81-4. PubMed ID: 7620816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increase of peripheral natural killer T cells in hemodialysis patients.
    Nishimoto A; Matsumoto Y
    Clin Nephrol; 2001 Feb; 55(2):121-6. PubMed ID: 11269675
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The unsuitability of BUN as a criterion for prescription dialysis.
    Shapiro JI; Argy WP; Rakowski TA; Chester A; Siemsen AS; Schreiner GE
    Trans Am Soc Artif Intern Organs; 1983; 29():129-34. PubMed ID: 6673221
    [No Abstract]   [Full Text] [Related]  

  • 74. [Uremic polyneuropathy. Case studies].
    Fierro B; Fradà G; Li Vecchi M; Raimondo D
    Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740
    [No Abstract]   [Full Text] [Related]  

  • 75. [Immunologic status of patients with endogenous bronchial asthma. II. Indicators of cellular immunity].
    Rogala B; Rogala E
    Pneumonol Pol; 1983; 51(8-9):469-74. PubMed ID: 6606160
    [No Abstract]   [Full Text] [Related]  

  • 76. [Levamisole-induced changes of cellular immunity in patients with staphyloderma and indications for levamisole administration].
    Lesnitskiĭ AI
    Vestn Dermatol Venerol; 1982; (1):14-9. PubMed ID: 6978577
    [No Abstract]   [Full Text] [Related]  

  • 77. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dialysis and the immune system.
    Stefoni S; DeSanctis LB; Nanni-Costa A; Iannelli S; Borgnino LC; Buscaroli A; Buttazzi R; La Manna G; Todeschini P; Giudicissi G
    Contrib Nephrol; 1995; 113():80-91. PubMed ID: 7712725
    [No Abstract]   [Full Text] [Related]  

  • 79. [Changes in serum profile of medium molecules in patients treated with dialysis for various lengths of time].
    Manari A; Buzio C; Calderini C; David S; Montagna G; Quaretti P; Gröf J; Migone L
    Minerva Nefrol; 1982; 29(2):93-100. PubMed ID: 7133545
    [No Abstract]   [Full Text] [Related]  

  • 80. [T- and B-lymphocyte in chronic glomerulonephritis and uremia].
    Kacprzyk F; Kuźmińska B; Orłwski Z
    Pol Tyg Lek; 1980 Dec; 35(48):1861-4. PubMed ID: 6970927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.